[1]
Zhao, X., Zhang, J., Liang, Y., Li, J., Ding, S., Wang, Y., Chen, Y. and Liu, J. 2021. Pharmacokinetics study of potential anti-CML drug Cyclobentinib (CB1107) by HPLC–MS/MS. Journal of Pharmaceutical and Biopharmaceutical Research. 3, 1 (Jun. 2021), 169-175. DOI:https://doi.org/10.25082/JPBR.2021.01.001.